Pfizer (PFE) Announces Strong Data from SUTENT Phase 3 in RCC; DFS Extension Noted
Tweet Send to a Friend
Pfizer Inc. (NYSE: PFE) announced results from the Phase 3 S-TRAC clinical trial (Sunitinib Trial as Adjuvant Treatment of Renal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
